Litcius/Paper detail

A brave new framework for glioma drug development

Kelly Hotchkiss, Philipp Karschnia, Karisa C. Schreck, Marjolein Geurts, Timothy F. Cloughesy, Jason T. Huse, Elizabeth S. Duke, Justin D. Lathia, David M. Ashley, Edjah K. Nduom, Georgina V. Long, Kirit Singh, Anthony J. Chalmers, Manmeet S. Ahluwalia, Amy B. Heimberger, Stephen Bagley, Tomoki Todo, Roel G.W. Verhaak, Patrick D. Kelly, Shawn L. Hervey‐Jumper, John de Groot, Anoop P. Patel, Peter E. Fecci, Ian F. Parney, Victoria Wykes, Colin Watts, Terry C. Burns, Nader Sanai, Matthias Preusser, J. C. Tonn, Katharine J. Drummond, Michael Platten, Sunit Das, Kirk Tanner, Michael A. Vogelbaum, Michael Weller, James R. Whittle, Mitchel S. Berger, Mustafa Khasraw

2024The Lancet Oncology25 citationsDOIOpen Access PDF

Topics & Concepts

GliomaDrug developmentDrugComputer scienceMedicinePharmacologyCancer researchGlioma Diagnosis and TreatmentATP Synthase and ATPases ResearchCancer, Hypoxia, and Metabolism